EUVIMEDEUVIMED entdecken
Crossref

Dinuclear Zinc(II) Complexes as Metallo-β-Lactamase Inhibitors with Antibiofilm Activity against MDR Gram-Negative Bacteria

Samik Biswas iD, Sujan Sk, Sangita Das, Soma Mondal, Sk Imran Ali iD, Supratim Mandal iD, Manindranath Bera iD

ACS Applied Bio Materials · 03.08.2026 · 9 (15) · 6983-7010

DOI: 10.1021/acsabm.6c00501 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Bio Materials, online erschienen am 22.07.2026. Verfasst von Samik Biswas und 6 weiteren Autor:innen. Beteiligte Einrichtung: Antimicrobial Resistance Research Laboratory, Department of Microbiology, University of Kalyani, Nadia, Kalyani, West Bengal741235, India. Hauptthemen laut MEDLINE: Biofilms, Zinc, Anti-Bacterial Agents, beta-Lactamase Inhibitors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 69 Literaturangaben. Gefördert von: Department of Science and Technology, Ministry of Science and Technology, India, Indian Council of Medical Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The alarming upsurge of multidrug-resistant (MDR) bacterial infection poses a serious burden to global health. The gradual restriction of advanced β-lactam-based antibiotic usage is mechanistically driven by bacterial metallo-β-lactamase (MBL) secretion, causing significant therapeutic failure and infection persistence. Furthermore, biofilm development has led to the disease scenario becoming more severe by restricting antibiotic penetration and immune responses. The present article describes a strategic design and development of dinuclear zinc(II) complex-based MBL inhibitors, coupled with antibacterial and antibiofilm activity against gram-negative MDR superbugs. Hence, a series of three dinuclear zinc(II) complexes, namely [Zn2L(Cl)(H2O)2]·4H2O (1), [Zn2L(NO3)(H2O)2]·4H2O (2) and [Zn2L(OAc)(H2O)2]·4H2O (3) were successfully constructed using the organic ligand, 2,6-bis[N-{N-(carboxymethyl)-N-(pyridylmethyl)amine}methyl]-4-methylphenol (H3L). Single crystal X-ray diffraction analysis revealed that the formation of complexes 1–3 was accomplished via the unsymmetrical metal-ligand coordination around the zinc centers, with five- and six-coordinate environments. The novelty of complexes 1–3 primarily lies in their effectiveness in antibacterial and antibiofilm properties, including MBL inhibitory application. Among these three dizinc complexes, 3 exhibited significant antibacterial activity against the clinical isolates of gram-negative MDR bacteria, such as Escherichia coli (Ec-CI-4), Acinetobacter baumannii (Ab-CI-2) and Klebsiella pneumonia (Kp-CI-5), with minimum inhibitory concentration (MIC) values of 250, 250 and 350 μg/mL, respectively. Again, complex 3 showed maximum biofilm reduction capability with 74.42, 77.45 and 69.37% for Ec-CI-4, Ab-CI-2 and Kp-CI-5, respectively. Our as-synthesized complex 3 also displayed MBL inhibitory activity as evidenced by nitrocefin analysis and in silico molecular docking study. Furthermore, the biofilm eradication nature of 3 was also found to be significant from the surfaces of urinary catheters and contact lenses, highlighting its future applicability potential. Therefore, complex 3 could emerge as an MBL inhibitor confronting MDR bacterial infections and medicinal implant-associated maladies as a significant therapeutic alternative over conventional antibacterial treatment regimens.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BiofilmsZincAnti-Bacterial Agentsbeta-Lactamase InhibitorsBiocompatible MaterialsGram-Negative BacteriaCoordination ComplexesMicrobial Sensitivity Testsbeta-LactamasesMolecular StructureDrug Resistance, Multiple, BacterialMaterials TestingDose-Response Relationship, Drug

Stichwörter der Autor:innen

X-ray crystallographyantibiofilm activitydinuclear zinc complexmetallo-β-lactamase inhibitormolecular dockingmultidrug resistance

Substanzen

ZincAnti-Bacterial Agentsbeta-Lactamase Inhibitorsbeta-LactamasesBiocompatible MaterialsCoordination Complexes

Autor:innen und Institutionen

  • Antimicrobial Resistance Research Laboratory, Department of Microbiology, University of Kalyani, Nadia, Kalyani, West Bengal741235, India.
  • Analytical Chemistry Section, Department of Chemistry, University of Kalyani, Nadia, Kalyani, West Bengal741235, India.
  • Department of Microbiology, College of Medicine & Jawaharlal Nehru Memorial (JNM) Hospital, WBUHS, Block A2, Kalyani, West Bengal741235, India.
  • Present Address: Antimicrobial Resistance Research Laboratory, Institute of Health Science, Presidency University, DG Block, Action Area I, New Town, Kolkata, West Bengal700156, India.

ORCID-Profile: Samik Biswas, Sk Imran Ali, Supratim Mandal, Manindranath Bera

Förderung

  • Department of Science and Technology, Ministry of Science and Technology, India
  • Indian Council of Medical Research

Zitieren

APA

Biswas, S., Sk, S., Das, S., Mondal, S., Ali, S. I., Mandal, S., & Bera, M. (2026). Dinuclear Zinc(II) Complexes as Metallo-β-Lactamase Inhibitors with Antibiofilm Activity against MDR Gram-Negative Bacteria. ACS Applied Bio Materials, 9(15), 6983-7010. https://doi.org/10.1021/acsabm.6c00501

Vancouver

Biswas S, Sk S, Das S, Mondal S, Ali SI, Mandal S, et al. Dinuclear Zinc(II) Complexes as Metallo-β-Lactamase Inhibitors with Antibiofilm Activity against MDR Gram-Negative Bacteria. ACS Applied Bio Materials. 2026;9(15):6983-7010. doi:10.1021/acsabm.6c00501

BibTeX
@article{Biswas2026,
  author = {Biswas, Samik and Sk, Sujan and Das, Sangita and Mondal, Soma and Ali, Sk Imran and Mandal, Supratim and Bera, Manindranath},
  title = {Dinuclear Zinc(II) Complexes as Metallo-β-Lactamase Inhibitors with Antibiofilm Activity against MDR Gram-Negative Bacteria},
  journal = {ACS Applied Bio Materials},
  year = {2026},
  volume = {9},
  number = {15},
  pages = {6983--7010},
  doi = {10.1021/acsabm.6c00501}
}
Kostenlos starten →